Skip to main content

Table 5 Fusion success at each time point (BMA)

From: Allogeneic morphogenetic protein vs. recombinant human bone morphogenetic protein-2 in lumbar interbody fusion procedures: a radiographic and economic analysis

Time point (months)

OsteoAMPĀ® with BMA (%) (nā€‰=ā€‰132)

OsteoAMPĀ® without BMA (%) (nā€‰=ā€‰94)

3

18.9

18.1

6

61.9

56.7

12

94.7

92.6

18

99.1

98.7